QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)

Helmerich & Payne Stock, A Lot More Upside Than Meets the Eye

Helmerich & Payne Stock price forecast

Key Points

  • China's reopening and latest removal of mask mandates has pushed pent-up demand for oil in the nation. This decision to reopen and ease off COVID restrictions has been reflected in the massive uptrend for the Chinese manufacturing PMI index readings. 
  • Helmerich & Payne is well positioned to benefit off the higher production needed to satisfy this increased demand for the commodity, as a leading drilling solutions provider with the strongest industry financials, analysts believe there is a massive upside in this stock. 
  • Increasing dividend payouts and share repurchases may just be the beginning for what the company has in store with regards to value creation for shareholders.
  • 5 stocks we like better than Helmerich & Payne

China's economy has woken up from its long COVID slumber. The 12-month trend for one of the most reliable economic activity indicators, the Caixin Manufacturing PMI, has crossed into expansion levels for the first time since. The latest readings have surprised global markets and attracted a lot of attention from investors who are seeking to generate some alpha in the country.

This is especially true given the PMI readings, which have come in hot at 54.20 (any reading above 50 signifies economic expansion accruing to GDP).

With Goldman Sachs Group NYSE: GS and the oil trading powerhouse Vitol Group have stated their projections and base case for oil reaching $100 per barrel and above by the fourth quarter of 2023. With markets overestimating U.S. production and underestimating the coming demand from China and India, as well as the ongoing transitions towards renewable energy, the commodity's price may very well fulfill those predictions.

Higher oil prices incentivize all market participants to seek alternative energy sources, which is in line with the agendas of many leaders today.

Like a good driller HP is there

In a few simplified words, this is the value proposition that Helmerich & Payne NYSE: HP delivers to their customers and investors. Big oil companies like BP NYSE: BP, Exxon Mobile NYSE: XOM and ConocoPhillips NYSE: COP look to HP as a leading provider of the equipment, personnel and machinery necessary to drill and explore for oil, and it is through these solutions and equipment contracts that the firm is in one of the best positions to benefit from the predictions made by top participants in the sector. 


As contract revenues vary with a performance clause tied directly to the price of oil and the demand expended by the customer, HP's contracts will deliver higher deliverables as oil prices are set to increase and major suppliers scramble to meet this higher demand amid tight supply.

Judge a book by its content

Speaking of books, investors can find a very interesting story, perhaps one that others may miss, by dissecting HP's income and cash flow statements. While the income statement and subsequent EPS may prove unsatisfying for investors, a better story can be found in the cash flow statement. 

The company generates earnings through leasing equipment and technology solutions so GAAP measures may distort its income statement greatly. However, looking at the cash flow statement, investors can find a hidden gem. With operating cash flows showcasing a 2017-2022 average margin of 21% and gross margins of 30.7%, HP is left with a cyclically adjusted ability to invest heavily in more efficient operations and, most importantly, create value for its shareholders.

According to HP's 2023 investor presentation, being able to invest heavily into R&D (at a 14% 6-year CAGR vs 2% revenue CAGR) has allowed the firm to become the preferred equipment and drilling solutions in the industry. Highlighting the achievement of revenue per rig level of $15 million USD in 2022 compared to $10 million USD in 2017 - that is a whopping 50% in 6 years - and allowing new technological and process breakthroughs to lower the overall CAPEX from over 30% to 18% in the same period.

Financial trifecta achieved

Lower capital intensity and higher revenue potential across their fixed asset base have allowed massive free cash flow yields for HP. These funds have allowed the company to achieve the most attractive capital structure within the peer group and be prosperous enough to return formidable cash to their shareholders as a result.

Carrying a 17% debt-to-total-capitalization structure on their balance sheet places HP above Patterson UTI Energy NASDAQ: PTEN with 33%, Nabors Industries NYSE: NBR with 83%, and Precision Drilling NYSE: PDS with 47%. Similar trends can be seen in their total liquidity of $1.2 billion USD, which is 200% of their total debt. No amount of crude oil volatility could throw HP off the strong leading position they have achieved.

HP' management has further decided to payout additional supplemental dividends for 2023. Following their guidance expecting cash flows from operations in the tune of $1.3 billion USD minus a CAPEX range for $425-$475 million USD, payouts in dividends plus share buybacks may come in around $310 million USD, or equivalent 5.5% to 7.5% total yield in cash returns alone. All the peers in the industry could not get even above 5% yield. 

Ready to order?

Analysts are pointing to $60.91 as a consensus price target in HP, which may not reflect the updated predictions for oil rising back above $120 per barrel. The truth of the matter is some may wallow in inflation while others can enjoy a 5-7% yield and some additional upside by adding HP to their beloved watchlists.

 

 

 

 

 

 

 

 

Should you invest $1,000 in Helmerich & Payne right now?

Before you consider Helmerich & Payne, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Helmerich & Payne wasn't on the list.

While Helmerich & Payne currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Helmerich & Payne (HP)
2.339 of 5 stars
$41.92+1.8%2.39%10.00Reduce$42.88
BP (BP)
3.9566 of 5 stars
$38.30+1.0%4.49%7.52Hold$43.72
ConocoPhillips (COP)
4.5607 of 5 stars
$129.61+1.4%1.79%14.31Moderate Buy$142.00
The Goldman Sachs Group (GS)
4.5304 of 5 stars
$405.61+0.6%2.71%15.84Moderate Buy$434.93
Precision Drilling (PDS)
1.3566 of 5 stars
$67.52+0.2%N/A4.96Buy$44.00
Patterson-UTI Energy (PTEN)
4.8289 of 5 stars
$11.39+0.4%2.81%11.28Moderate Buy$16.17
Nabors Industries (NBR)
1.6842 of 5 stars
$76.79-0.3%N/A-14.88Hold$129.60
Compare These Stocks  Add These Stocks to My Watchlist 

Gabriel Osorio-Mazilli

About Gabriel Osorio-Mazilli

  • gosoriomazzilli@gmail.com

Contributing Author

Value Stocks, Asian Markets, Macro Economics

Experience

Gabriel Osorio-Mazilli has been a contributing writer for MarketBeat since 2023.

Areas of Expertise

Value investing, long/short trading, options, emerging markets

Education

CFA Level I candidate; Goldman Sachs corporate training; independent courses

Past Experience

Analyst at Goldman Sachs, associate at Citigroup, senior financial analyst in real estate


Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: